Read Incubate’s response to the FTC’s Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers
Incubate advocates for the patient, corporate, and investment communities by educating policymakers on the role of venture capital in bringing promising, innovative treatments to patients in need.
What We Do
Help ensure a level global playing field for investment and promote policies that empower life science innovators to build and grow in the United States.
Strengthen and protect U.S. intellectual property provisions by promoting patent and regulatory systems that encourage life sciences innovation.
Amplify the results
Spotlight the venture capital-driven breakthroughs that are transforming medicine for patients and health professionals around the globe.
This episode of Making Medicine features Dr. Henry Skinner, CEO of the AMR Action Fund, who discusses the urgency of finding solutions for AMR and how the fund aims to help.
In this episode, Making Medicine Host John Stanford is featured as a guest, as he discusses the policy outlook for 2022 with Ashlyn Roberts, our Coalition Manager.
See Executive Director John Stanford’s statement on CMS’ Final NCD on Alzheimer’s disease and how this will affect the future of biopharmaceutical investment.
Stories from the Early-Stage Life Sciences Ecosystem
Listen to industry experts delve into the process behind scientific breakthroughs (and how many of them almost never happened), where the life science ecosystem is taking us next, and most importantly, what it means for patients.
Level Setting: The Role of Government in Healthcare
Cure has launched a weekly symposia that is intended to advance thought in healthcare, management, innovation, policy, and other relevant…